3142
S. K. Quek et al. / Tetrahedron 62 (2006) 3137–3145
[C8H15NC2 ] (100) and lighter fragments. MS (ESI negative,
ion energy 0.3 eV), m/z (%): 580.0 [(C4F9SO2)2NK] (100)
and lighter fragments.
135.9 (N–CH]N). 19F NMR (376.59 MHz): d K127.0 (4F,
t*, JZ14 Hz, 2CF2-3), K122.0 (4F, mc, 2CF2-2), K113.8
(4F, br t, JZ14 Hz, 2CF2-1), K82.0 (6F, tt, J1Z9.9 Hz,
*
J2Z2.3 Hz, 2CF3); further splitting due to the multiple
19F,19F couplings. MS (ESI positive, ion energy 0.3 eV), m/z
(%): 139.1 [C8H15NC2 ] (100) and lighter fragments. MS
(ESI negative, ion energy 0.3 eV), m/z (%): 580.0
[(C4F9SO2)2NK] (100) and lighter fragments.
3.2.4. 1-Pentyl-3-methylimidazolium bis(nonafluoro-
butane-1-sulfonyl)imide (1d). The title compound was
prepared from N-methylimidazole (1.172 g, 14.3 mmol),
Me(CH2)4Br (2.27 g, 15.0 mmol) and the salt A (8.42 g,
13.6 mmol) as described in GP1; yield 9.66 g (97%) as a
clear yellowish viscous liquid. 1d, 1H NMR (400.23 MHz):
d 0.87 (3H, t, 3JZ7 Hz, CH2CH3), 1.23–1.38 (4H, m,
3.2.7. 1-Isopropyl-3-methylimidazolium bis(nonafluoro-
butane-1-sulfonyl)imide (1g). The title compound was
prepared from N-methylimidazole (1.22 g, 14.9 mmol),
Me2CHBr (1.93 g, 15.7 mmol) and the salt A (8.79 g,
14.2 mmol) as described in GP1; yield 9.87 g (99%) as
a slightly yellowish deliquescent crystalline solid, mp
3
CH2CH2CH3), 1.84 (2H, quintet, JZ7.5 Hz, NCH2CH2),
3
3.91 (3H, s, NCH3), 4.14 (2H, t, JZ7.6 Hz, NCH2), 7.32
(1H, t, JZ1.8 Hz) and 7.33 (1H, t, JZ1.8 Hz) (both
CH]CH), 8.73 (1H, br s, N–CH]N). 13C NMR
(100.65 MHz): d 13.4 (CH2CH3), 21.8 (CH2CH3), 28.0
and 29.7 (both CH2) 36.0 (NCH3), 50.0 (NCH2), 122.2 and
123.7 (both CH]CH), 135.9 (N–CH]N). 19F NMR
(376.59 MHz): d K127.1 (4F, t*, JZ14 Hz, 2CF2-3),
K122.2 (4F, mc, 2CF2-2), K114.0 (4F, br t, JZ14 Hz,
2CF2-1), K82.0 (6F, tt, J1Z9.9 Hz, J2Z2 Hz, 2CF3);
*further splitting due to the multiple 19F,19F couplings.
MS (ESI positive, ion energy 0.3 eV), m/z (%): 153.172
[C9H17NC2 ] (100) and lighter fragments. MS (ESI negative,
ion energy 0.3 eV), m/z (%): 579.951 [(C4F9SO2)2NK]
(100) and lighter fragments.
1
28–29 8C. 1g, H NMR (400.23 MHz, DMSO-d6): d 1.48
(6H, d, 3JZ6.7 Hz, Me2CH), 3.85 (3H, s, NCH3), 4.63 (1H,
3
heptet, JZ6.7 Hz, NCHMe2), 7.71 (1H, t, JZ1.8 Hz) and
7.87 (1H, t, JZ1.8 Hz) (both CH]CH), 9.17 (1H, br s,
N–CH]N). 13C NMR (100.65 MHz, DMSO-d6): d 22.3
(Me2CH), 35.7 (NCH3), 52.2 (NCHMe2), 120.5 and 123.7
(both CH]CH), 135.4 (N–CH]N). 15N NMR
(40.57 MHz, DMSO-d6): d K183.6 and K210.4 (both
endocyclic N). 19F NMR (376.59 MHz, DMSO-d6): d
K128.1 (4F, t*, JZ14 Hz, 2CF2-3), K123.3 (4F, mc,
2CF2-2), K115.6 (4F, br t, JZ14 Hz, 2CF2-1), K82.8 (6F,
*
tt, J1Z9.8 Hz, J2Z2.6 Hz, 2CF3); further splitting due to
the multiple 19F,19F couplings. MS (ESI positive, ion energy
0.3 eV), m/z (%): 125.114 [C7H13NC2 ] (100) and lighter
fragments. MS (ESI negative, ion energy 0.3 eV), m/z (%):
579.950 [(C4F9SO2)2NK] (100) and lighter fragments.
3.2.5. 1-(3-Methyl-butyl)-3-methylimidazolium bis(nona-
fluorobutane-1-sulfonyl)imide (1e). The title compound
was prepared from N-methylimidazole (1.223 g,
14.9 mmol), Me2CH(CH2)2Br (1.93 g, 15.7 mmol) and the
salt A (8.42 g, 13.6 mmol) as described in GP1; yield 9.97 g
(O99%) as a yellowish crystalline solid, mp 39–40 8C. 1e,
1H NMR (400.23 MHz, DMSO-d6): d 0.92 (6H, d,
3JZ6.7 Hz, Me2CH), 1.52 (1H, nonet, 3JZ6.7 Hz,
Me2CH), 1.70 (2H, dt, 3J1Z7.8 Hz, 3J2Z6.7 Hz,
3.2.8. 1-sec-Butyl-3-methylimidazolium bis(nonafluoro-
butane-1-sulfonyl)imide (1h). The title compound was
prepared from N-methylimidazole (1.20 g, 14.6 mmol),
MeCH2CH(Me)Br (2.10 g, 15.3 mmol) and the salt A
(7.25 g, 11.7 mmol) as described in GP1; yield 8.38 g
(O99%) as a clear viscous tawny liquid. 1h, 1H NMR
(400.23 MHz, DMSO-d6): d 0.78 (3H, t, 3JZ7.4 Hz,
CH3CH2), 1.47 (3H, d, 3JZ6.9 Hz, CH3CH), 1.80
(2H, mc, CH3CH2), 3.86 (3H, s, NCH3), 4.41 (1H, sextet,
3JZ6.9 Hz, NCH), 7.73 (1H, t, JZ1.7 Hz) and 7.86 (1H, t,
JZ1.7 Hz) (both CH]CH), 9.17 (1H, br s, N–CH]N). 13C
NMR (100.65 MHz, DMSO-d6): d 9.9 (CH2CH3), 20.2
(CH3CHN), 29.1 (CH2CH3), 35.8 (NCH3), 57.8 (NCH),
120.4 and 123.9 (both CH]CH), 135.7 (N–CH]N).
19F NMR (376.59 MHz, DMSO-d6): d K128.1 (4F, t*,
JZ14 Hz, 2CF2-3), K123.4 (4F, mc, 2CF2-2), K115.7
(4F, br t, JZ14 Hz, 2CF2-1), K82.8 (6F, tt, J1Z9.8 Hz,
3
NCH2CH2), 3.85 (3H, s, NCH3), 4.18 (2H, t, JZ7.6 Hz,
NCH2), 7.69 (1H, t, JZ1.8 Hz) and 7.78 (1H, t, JZ1.8 Hz)
(both CH]CH), 9.12 (1H, br s, N–CH]N). 13C NMR
(100.65 MHz, DMSO-d6): d 21.9 (Me2CH), 24.8 (Me2CH),
35.7 (NCH3), 38.2 (NCH2CH2), 47.2 (NCH2), 122.3 and
123.6 (both CH]CH), 136.5 (N–CH]N). 19F NMR
(376.59 MHz, DMSO-d6): d K128.1 (4F, t*, JZ14 Hz,
2CF2-3), K123.4 (4F, mc, 2CF2-2), K115.7 (4F, br t, JZ
14 Hz, 2CF2-1), K82.8 (6F, tt, J1Z9.8 Hz, J2Z2.6 Hz,
2CF3); *further splitting due to the multiple 19F,19F
couplings. MS (ESI positive, ion energy 0.3 eV), m/z (%):
153.2 [C9H17NC2 ] (100) and lighter fragments. MS
(ESI negative, ion energy 0.3 eV), m/z (%): 580.0
[(C4F9SO2)2NK] (100) and lighter fragments.
*
J2Z2.6 Hz, 2CF3); further splitting due to the multiple
19F,19F couplings. MS (ESI positive, ion energy 0.3 eV), m/z
(%): 139.1 [C8H15NC2 ] (100) and lighter fragments. MS
(ESI negative, ion energy 0.3 eV), m/z (%): 580.0
[(C4F9SO2)2NK] (100) and lighter fragments.
3.2.6. 1-Isobutyl-3-methylimidazolium bis(nonafluoro-
butane-1-sulfonyl)imide (1f). The title compound was
prepared from N-methylimidazole (1.20 g, 14.6 mmol),
Me2CHCH2Br (1.42 g, 15.3 mmol) and the salt A (8.61 g,
13.9 mmol) as described in GP1; yield 9.99 g (O99%) as a
clear yellowish viscous liquid. 1f, 1H NMR (400.23 MHz):
d 0.94 (6H, d, 3JZ6.7 Hz, Me2CH), 2.15 (1H, nonet,
3JZ6.8 Hz, Me2CH), 3.95 (3H, s, NCH3), 4.00 (2H, t,
3JZ7.4 Hz, NCH2), 7.39 (1H, t, JZ1.8 Hz) and 7.41 (1H, t,
JZ1.8 Hz) (both CH]CH), 8.72 (1H, br s, N–CH]N). 13C
NMR (100.65 MHz): d 18.6 (Me2CH), 29.1 (Me2CH), 35.8
(NCH3), 56.7 (NCH2), 122.7 and 123.6 (both CH]CH),
3.2.9. 1-Propyl-3-methylimidazolium nonafluorobutane-
sulfonate (2a). The title compound was prepared from
N-methylimidazole (2.044 g, 24.9 mmol), Me(CH2)2Br
(3.21 g, 26.1 mmol) and the salt B (8.00 g, 23.7 mmol) as
described in GP1; yield 8.25 g (82%) as a slightly yellowish
crystalline solid, mp 33–34 8C. 2a, 1H NMR (400.23 MHz):
d 0.94 (3H, t, 3JZ7.4 Hz, CH2CH3), 1.90 (2H, sextet,
3JZ7.4 Hz, CH2CH3), 3.96 (3H, s, NCH3), 4.15 (2H, t,